The Food and Drug Administration recently made an announcement regarding the approval of GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 50 to 59. This expansion of approval aims to safeguard individuals within this age group who are at a higher risk of experiencing severe complications from the virus. RSV is known to
Business
The recent bankruptcy of Synapse, a fintech middleman, has revealed a significant issue in the sector. A court-appointed trustee has reported an $85 million shortfall between what depositors are owed and what partner banks are holding. This revelation has sent shockwaves through the fintech industry, causing concern among customers and stakeholders alike. The missing funds
The recent development in contract talks between American Airlines and the Association of Professional Flight Attendants has brought to light the ongoing struggle for fair wages. Despite CEO Robert Isom’s proposal to immediately raise pay by 17%, the union representing American Airlines flight attendants rejected the offer. This decision has potentially brought the threat of
Boeing CEO Dave Calhoun is set to testify before a Senate panel on June 18th in response to whistleblower allegations and concerns about quality control within the aircraft manufacturing company. Senator Richard Blumenthal, chairman of the Senate Permanent Subcommittee on Investigations, expressed the importance of Calhoun’s testimony in addressing Boeing’s failures and rebuilding public trust
Lululemon, a leading athletic apparel retailer, recently reported flat comparable sales in its largest market, the Americas, raising concerns about its growth trajectory. While the company exceeded earnings expectations, it only narrowly beat revenue projections, signaling a potential slowdown in its key region. The company’s full fiscal year guidance suggests optimism for improved conditions in
Paramount Global’s current leadership, consisting of CBS CEO George Cheeks, Paramount Media Networks CEO Chris McCarthy, and Paramount Pictures CEO Brian Robbins, recently unveiled a plan at the company’s annual shareholder meeting. This plan outlines strategic priorities, which include exploring joint venture opportunities in the streaming industry with other media companies, cutting costs by $500
Modern and Merck recently released positive three-year data on their experimental vaccine, combined with Keytruda therapy, for patients with deadly skin cancer. The vaccine showed promising results in improving survival rates and long-lasting efficacy in midstage study participants at the American Society of Clinical Oncology annual meeting. The study revealed that the combination of the
The recent reports of Paramount and Skydance reaching a merger agreement have sent shockwaves through the entertainment industry. The deal, which is estimated to be worth $8 billion, has left many wondering about the implications for both companies and the future of Paramount. However, upon closer inspection, it becomes evident that there are several aspects
In 2019, Adam Moelis embarked on a mission to revolutionize the way Americans save money through his fintech startup, Yotta. However, what started as a noble endeavor soon turned into a nightmare for thousands of customers who found themselves unable to access their funds due to a dispute between Yotta’s banking partners, Synapse and Evolve
In a recent announcement, the Food and Drug Administration granted approval for Moderna’s vaccine for respiratory syncytial virus (RSV) for adults aged 60 and older. This marks a significant milestone for Moderna, as it diversifies its product portfolio beyond its Covid jab, which has seen a decrease in demand. The decision to approve Moderna’s RSV